Individual genotype influences effectiveness of HIV vaccine
Almost 40 million people worldwide live with HIV/AIDS. Despite great effort, HIV-1 vaccine development has been challenging. A recent HIV vaccine trial, known as RV144, revealed that a combination of 2 vaccines protected some individuals from HIV infection. Individuals in the trial that made antibodies that bound to a specific region of the HIV envelope […]
